CHARLOTTESVILLE, VA –August 2, 2010 – Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled “Bipolar Trans Carotenoid Salts and Their Uses.” This patent includes drug formulation and use claims relating to Diffusion’s entire family of first-in-class new chemical entities. [...]
CHARLOTTESVILLE, VA — June 6, 2006 — Diffusion Pharmaceuticals LLC, a drug discovery and development company, today announced that VaBIO, a membership organization that promotes the scientific and economic impact of the life sciences industry in the Commonwealth of Virginia, awarded it for the third year a $1,500 grant as part of the organization’s Summer [...]
Charlottesville, VA, June 15, 2005—The Virginia Piedmont Technology Council (VPTC), the most vibrant tech-focused business alliance in Central Virginia, elected its officers and board of directors for 2005-2006 at the Council’s annual membership lunch held on Wednesday, June 15. Outgoing Chair, Suzanne Jackson, President of Four Leaf Public Relations, handed the gavel to incoming Chair, [...]
Charlottesville, VA — October 29, 2004 —Diffusion Pharmaceuticals LLC, a pharmaceutical company which discovers and develops novel small-molecule therapeutics for the treatment of oxygen deficiency in tissues, today announced its selection as the winner of the Virginia’s Technology Capital Access Forum’s (VTCAF) business plan competition, receiving the $10,000 cash prize sponsored by Third Security, LLC. [...]
CHARLOTTESVILLE, VA — Tuesday, September 7, 2004 — Diffusion Pharmaceuticals, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced it has been awarded a $1 million appropriation in the FY 2005 Defense Budget, which President Bush signed last month. These funds are allocated for studies to advance its lead compound, trans [...]
